Loteprednol/tobramycin: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 38: | Line 38: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 18:07, 17 March 2025
Loteprednol/Tobramycin is a combination medication used in the treatment of bacterial infections and inflammation in the eye. It contains two active ingredients: Loteprednol, a corticosteroid, and Tobramycin, an antibiotic.
Indications[edit]
Loteprednol/Tobramycin is indicated for the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. These conditions include conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis.
Mechanism of Action[edit]
Loteprednol works by reducing inflammation in the eye by inhibiting the release of substances in the body that cause inflammation. Tobramycin, on the other hand, works by stopping the growth of bacteria. It does this by binding to components of the bacterial cell leading to the inhibition of protein synthesis and thus bacterial growth.
Side Effects[edit]
Common side effects of Loteprednol/Tobramycin include blurred vision, eye discomfort, and sensitivity to light. More serious side effects may include eye pain, vision changes, and continued redness or irritation of the eye.
Contraindications[edit]
Loteprednol/Tobramycin is contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.
Drug Interactions[edit]
Loteprednol/Tobramycin may interact with other medications, including other eye medications. It is important to inform your healthcare provider about all other medications you are currently taking.
See Also[edit]
References[edit]
External Links[edit]
